NRG1: a cinderella fusion in lung cancer?-Reference-Cited by-同舟云学术

NRG1: a cinderella fusion in lung cancer?

Published:2017-12 Issue:4 Volume:6 Page:121-123
ISSN:1758-1966
Container-title:Lung Cancer Management
language:en
Short-container-title:Lung Cancer Management

Author:

Muscarella Lucia Anna¹,Rossi Antonio²

Affiliation:

1. Laboratory of Oncology, Scientific Institute for Research & Health Care (IRCCS) ‘Casa Sollievo della Sofferenza’, San Giovanni Rotondo (FG), Italy

2. Division of Medical Oncology, Scientific Institute for Research & Health Care (IRCCS), Casa Sollievo della Sofferenza Hospital, Viale Cappuccini 1, 71013, San Giovanni Rotondo (FG), Italy

Publisher

Future Medicine Ltd

Subject

Pulmonary and Respiratory Medicine,Oncology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/lmt-2017-0018

Reference20 articles.

1. Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

2. Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer

3. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance

4. CD74–NRG1 Fusions in Lung Adenocarcinoma

5. The ERBB network: at last, cancer therapy meets systems biology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer;BMC Medicine;2024-02-19

2. Oncogenic alterations in advanced NSCLC: a molecular super-highway;Biomarker Research;2024-02-12

3. Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics;Pharmaceuticals;2023-04-19

4. Cancer prognosis and immune system;Microbial Crosstalk with Immune System;2022

5. Neuregulin 1 Gene (NRG1). A Potentially New Targetable Alteration for the Treatment of Lung Cancer;Cancers;2021-10-09